Financials
- Market Capitalization 1.34 B
- Employee 104
- Founded 2005
- CEO N/A
- Website www.anaptysbio.com
- Headquarter Delaware, United States
- FIGI BBG0026ZDHR0
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-105.39
市销率
5.94
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2200 | NKTR Nektar Therapeutics - Common Stock | 39.84 USD | -3.23% | -6.13% | -43.09% | -45.63% | 1.36 B USD | ||
| 2208 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 4.14 USD | -7.80% | -8.81% | -17.20% | -17.03% | 1.35 B USD | ||
| 2218 | INBX Inhibrx Biosciences, Inc. - Common Stock | 90.53 USD | -4.72% | -5.22% | -17.02% | +12.35% | 1.33 B USD | ||
| 2252 | DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.26 USD | -1.04% | -4.81% | +1.06% | +264.71% | 1.26 B USD |